Inhibition of intimal/medial hyperplasia by perindopril in canine vein grafts

Annals of Vascular Surgery

Volumn 19, Issue 4, 2005, Pages 499-506

  Flores, Jorge ^a   Kunihara, Takashi ^a   Shiiya, Norihiko ^a   Nishibe, Toshiya ^b   Kudo, Fabio ^a   Yasuda, Keishu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PERINDOPRIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; JUGULAR VEIN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; VEIN GRAFT;

EID: 23744456850     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-4792-5     Document Type: Article

References (39)

1. Dzau VJ. Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 1993;22(Suppl. 5):S1-S9.
2. Matsumoto K, Morishita R, Moriguchi A, et al. Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model. Hypertension 2001;37:270-274.
3. Berk BC, Vekshtein V, Gordon HM, et al. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13:305-314.
4. Renaud IM, Chainey A, Belair MF, et al. Long-term protection of obese Zucker rat kidneys form fibrosis and renal failure with an angiotensin- converting enzyme inhibitor/diuretic combination. Fundam Clin Pharmacol 2004;18:437-447.
5. Roux SP, Clozel JP, Kuhn H. Cilazapril inhibits wall thickening of vein bypass graft in the rat. Hypertension 1991;18(Suppl.):43-46.
6. Borland JAA, Chester AH, Crabbe S, et al. Differential action of angiotensin II and activity of angiotensin-converting enzyme in human bypass grafts. J Thorac Cardiovasc Surg. 1998;116:206-212.
7. Hirko MK, McShannic JR, Schmidt SP, et al. Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts. J Vasc Surg 1993;17:877-887.
8. O'Donohoe MK, Schwartz LB, Radic ZS, et al. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts. Ann Surg 1991;214:727-732.
9. Goncalves RG, Biato MA, Colosimo RDG, et al. Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats. Am J Nephrol 2004;24:527-536.
10. Nishimoto M, Takai S, Sawada Y, et al. Chymase-dependent angiotensin II formation in the saphenous vein versus the internal thoracic artery. Cardiovasc Surg 2001;121:729-734.
11. Okunishi H, Oka Y, Shiota N, et al. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993;62:207-210.
12. Takai S, Jin D, Sakaguchi M, et al. Chymase-dependent angiotensin II formation in human vascular tissue. Circulation 1999;100:654-658.
13. Janiak P, Pillon A, Prost JF, et al. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 1992;20:737-745.
14. O'Donohoe MK, Hagen P-O. New concepts of renin-angiotensin system-implications for vascular and endovascular surgery. Eur J Vasc Endovasc Surg 1996;11:393-401.
15. Van Belle E, Bauters C, Wernert N, et al. Angiotensin converting enzyme inhibition prevents proto-oncogene expression in the vascular wall after injury. J Hypertens 1995;13:105-112.
16. Hanson SR, Powell JS, Dodson T, et al. Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension 1991;18(Suppl.):70-76.
17. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-110.
18. Faxon DP, Multicenter American Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction, Restenosis (MARCATOR) Study Group. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Cardiol 1995;25:362-369.
19. Roks A, Buikema H, Pinto YM, et al. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I. Heart Vessels 1997;12(Suppl):119- 124.
20. Powell JS, Clozel JP, Muller RKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-188.
21. Raguki H, Wang DS, Dzau VJ, et al. Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointima formation. Circulation 1994;90:449-455.
22. Falkenhahn M, Gohlke P, Paul M, et al. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. J Cardiovasc Pharmacol 1994;24(Suppl. 2):S6-S13.
23. Lilly LS, Pratt RE, Alexander RW, et al. Cultured vascular endothelial cells contain the complete renin-angiotensin system. Clin Res 1983;31:332A.
24. Rogerson FM, Chai SY, Schlawe I, et al. Presence of angiotensin converting enzyme in the adventitia of large blood vessels. J Hypertens 1992;10:615-620.
25. Zhuo JL, Froomes P, Casley D, et al. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease. Circulation 1997;96:272-280.
26. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 1987;9:178-187.
27. Clozel JP, Hess P, Michael C, et al. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension 1991;18(4Suppl.):55-59.
28. Raguki H, Kim DK, Krieger JE, et al. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest 1994;93: 339-346.
29. O'Donohoe MK, Davies MG, Radic ZS, et al. Increased concentrations of angiotensin-converting enzyme in intimal hyperplasia of experimental vein grafts. J Cardiovasc Pharmacol 1994;23:594-601.
30. Nishibe T, Miyazaki K, Kudo F, et al. Induction of angiotensin converting enzyme in neointima after intravascular stent placement. Int Angiol 2002;21:250-255.
31. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424.
32. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy vs. hyperplasia. J Clin Invest 1992;90:456-461.
33. Itoh H, Mukoyama M, Pratt RE, et al. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268-2274.
34. Noguchi R, Yoshiji H, Kuriyama S, et al. Combination of interferon-β and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis. Clin Cancer Res 2003;9:6038-6045.
35. Furukawa Y, Matsumori A, Hirozane T, et al. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril. Circulation 1996;93:333-339.
36. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
37. Diez J, Panizo A, Hernandez M, et al. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension 1997;29:776-780.
38. Janiak P, Libert O, Vilaine JP. Role of the renin-angiotensin system in neointima formation after injury in rabbits. Hypertension 1994;24:671-678.
39. 1 blockade in the remodeling following myocardial infarction. Basic Res Cardiol 1998;93(Suppl. 2):92-100.